Last News
-
30-11-2009: Cellerix appoints José Luis Bravo VP Global Medical and Regulatory
-
10-11-2009: Cellerix raises €27 million in a first closing
YSIOS, LSP and VENTECH led this financing round together with Genetrix and also joined by new investors
-
20-10-2009: Gamida Cell and Cellerix Partner on Feasibility Study
Pre-clinical study will test new method of improving clinical efficacy of expanded populations of adult stem cells obtained from adipose tissue
-
6-09-2009: Cellerix’s Cx601 designated Orphan Medicinal product by the EMEA
Third medicine developed by Cellerix that obtains this designation
-
12-07-2009: Cinco Días - Cell Therapy that fulfills its promise
The Spanish biopharmaceutical company Cellerix is developing the first pharmaceutical product based on adipose tissue derived adult stem cells to be approved in Europe